introduction
The “Severe Acute Respiratory Syndrome Coronavirus 2” 1 (SARS-CoV-2) potentially causes fatal disease named “Covid-19” 2 . The Incubation period is between 2 days to 2 weeks after being exposed to the virus3 .
Most common clinical manifestations at the onset of disease include rhinorrhea, fever, cough, headache and myalgia. SARS-COV-2 seems to have particular affinity with nervous system; manifestations like hyposmia and hypogeusia are pathognomonic4.
In more severe cases, individuals may require hospitalization and even admission into the intensive unit care because the disease may unexpectedly cause different complications like Acute Respiratory Distress Syndrome (ARDS), which eventually may lead to death in a short time5. Pregnant women represent a patient population vulnerable to covid 19 virus infection due to their reduced immune defense. They are a challenge for anesthesiological management6,7,8.
Many strategies were performed to reduce the virus spread but the Covid-19 vaccine is certainly the most effective weapon.
The nucleic acid-genetic approach is a new way of developing vaccines. Before the COVID-19 pandemic. Because of the pandemic, the research in this area has progressed very fast and some mRNA vaccines for COVID-19 are getting emergency use authorization9.
Like any vaccine, COVID-19 vaccines can cause side effects, most of which are mild or moderate and vanish within a few days on their own. Typical side effects include pain at the injection site, fever, fatigue, headache, muscle pain, chills and diarrhea, even though more serious or long-lasting side effects are possible. National authorities and international bodies, including World Health Organization (WHO), are closely monitoring for any unexpected side effects following COVID-19 vaccine us9.
The aim of our case report is to present a rare post-vaccine side effect like Guillian Barré Syndrome (GBS).